China Shineway Pharmaceutical Group (CSWYY) Stock Price, News & Analysis

Company Overview

China Shineway Pharmaceutical Group Co., Ltd. is a China-based veterinary pharmaceutical company primarily engaged in the research, development, production and distribution of veterinary vaccines and biologics. The company’s product portfolio includes live attenuated vaccines, inactivated bacterins, recombinant subunit vaccines and diagnostic reagents designed to prevent and control infectious diseases in livestock, poultry and aquaculture. In addition to vaccines, Shineway manufactures veterinary antibiotics, feed additives and disinfectants for animal health management.

Headquartered in Langfang City, Hebei Province, China Shineway operates multiple production facilities across Hebei, Sichuan and Shandong provinces. These facilities adhere to Good Manufacturing Practices (GMP) standards and are equipped for large-scale fermentation, antigen purification and aseptic filling. The company’s integrated supply chain covers raw material sourcing, in-house vaccine formulation, quality control testing and nationwide distribution networks.

Founded in 1994, China Shineway has grown to become one of China’s leading suppliers of veterinary biologics, serving both domestic and international markets. The company’s export footprint extends to Southeast Asia, the Middle East, Africa and Latin America, where its vaccines are used in government-led animal disease control programs as well as private veterinary practices. China Shineway also collaborates with research institutes and provincial animal health centers on epidemiological surveillance and vaccine efficacy trials.

Research and development is a core focus for China Shineway. The company maintains R&D centers dedicated to pathogen strain isolation, antigen engineering and novel delivery systems. By leveraging molecular biology and immunology platforms, China Shineway aims to expand its pipeline of next-generation vaccines targeting emerging and re-emerging animal diseases. Its ongoing investments in innovation underpin efforts to enhance vaccine safety, efficacy and production efficiency.

Key Stats

• Today's Range: C$18.94 to C$18.94
• 50-Day Range: C$18.94 to C$19.25
• 52-Week Range: C$18.53 to C$19.25
• Volume: N/A
• Average Volume: 200 shs
• Market Capitalization: N/A
• P/E Ratio: 1.11
• Dividend Yield: 23.15%
• Price Target: N/A
• Consensus Rating: N/A

CSWYY Stock Analysis - Frequently Asked Questions

How have CSWYY shares performed this year?

China Shineway Pharmaceutical Group's stock was trading at C$18.53 at the beginning of 2025. Since then, CSWYY stock has increased by 2.2% and is now trading at C$18.94.

How do I buy shares of China Shineway Pharmaceutical Group?

Shares of CSWYY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Ex-Dividend for 10/14 Dividend: 9/10/2025
• Record date for 10/14 Dividend: 9/11/2025
• Dividend Payable: 10/14/2025
• Today: 10/16/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CSWYY
• CIK: N/A
• Web: www.shineway.com
• Phone: 86 31 1880 30066
• Fax: N/A
• Employees: 3,533
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 1.11
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A